Adaeze was 33 and planning to start trying for a baby at 36. Her AMH came back at 0.7 — significantly below normal for her age. At 36, her ovarian reserve would likely be even lower. With this information, she revised her plans — and conceived naturally at 34.
Lawyer, Lagos Island. Not currently trying to conceive — planning to start at 35–36. Attended for fertility health check after a friend's early menopause at 34. AMH: 0.7 ng/mL (significantly low for age; expected: > 2.0 ng/mL at age 33). Antral follicle count on scan: 4 per ovary. Diminished ovarian reserve confirmed.
AMH (Anti-Müllerian Hormone)Adaeze had a plan. She would make partner at her firm by 35, start trying for a baby at 36, and have her first child at 37. She was successful, disciplined, and had mapped out the next decade with the same precision she applied to her legal cases. She had no reason to think fertility would be a problem.
Then her closest friend — 34, no known medical issues — was told she had entered premature menopause. Her AMH was undetectable. She would not conceive without donor eggs. Adaeze had sat with her friend through the appointments and the grief. Three weeks later, she booked a fertility health check for herself.
"I'm not trying to conceive yet," she told the Mascot Healthcare doctor. "I just want to know what I'm working with." The AMH result came back: 0.7 ng/mL. The doctor explained gently: "For a 33-year-old, we would expect to see AMH above 2.0. Yours is significantly low. Your ovarian reserve is declining faster than average. The plan to start trying at 36 needs to be reconsidered."
AMH (anti-Müllerian hormone) is produced by the small follicles in the ovaries. It is the most accurate blood marker of the remaining egg supply — the ovarian reserve. It does not predict fertility directly, but low AMH signals that the window of natural fertility may be shorter than expected.
Reflects the quantity of remaining egg follicles. Normal at age 33: 2.0–6.8 ng/mL. Low: < 1.0 ng/mL. Very low: < 0.3 ng/mL. Adaeze's: 0.7.
Small resting follicles visible on pelvic ultrasound Day 2–5 of cycle. Normal: 10–20 total. Low: < 7 total. Adaeze's: 4 per ovary (8 total — borderline).
Elevated FSH (> 10 IU/L on Day 3) signals the pituitary working harder to stimulate a declining ovarian reserve.
Elevated Day 3 oestradiol suppresses FSH artificially — combined with FSH gives a fuller picture of ovarian reserve.
AMH declines with age in all women. The rate of decline varies significantly — some 35-year-olds have AMH of a 28-year-old; some 28-year-olds have AMH of a 38-year-old. Testing reveals where you fall.
AMH declines continuously with age — and the rate of decline accelerates in women with diminished ovarian reserve. A woman with AMH of 0.7 at 33 may have AMH of 0.2–0.3 at 36. At that level, natural conception becomes significantly harder and IVF success rates decline sharply.
The AMH test gave Adaeze information she could act on — at 33, her natural fertility, while lower than expected, was still meaningful. At 36, the window would likely be narrower. The test did not take away her plan — it gave her the information to modify it.
Adaeze was referred to a fertility specialist for a full consultation. Options discussed: try to conceive naturally sooner than planned; consider elective egg freezing (fertility preservation) while her egg quality remained reasonable; IVF when ready.
She and her husband discussed the results. They agreed to start trying naturally — not at 36, but now. Three months of timed intercourse with follicular tracking at Mascot Healthcare. At the second tracked cycle, a dominant follicle was confirmed on Day 11. She conceived that cycle.
Confirmation scan at 6 weeks: viable intrauterine pregnancy, FHR 122 bpm. She delivered a healthy girl at 38 weeks and 4 days.
AMH 0.7 ng/mL (low for age 33). AFC 8 (borderline). FSH Day 3: 9.2 IU/L (borderline elevated). Diminished ovarian reserve confirmed.
Fertility specialist referral; revised conception timeline (sooner); follicular tracking; natural conception attempted; egg freezing counselled as option.
Conceived naturally at second tracked cycle (age 33 years 8 months). Healthy delivery at 38 weeks.
Adaeze delivered a healthy daughter at 34. The AMH result at 33 gave her the information to revise her timeline — and the time to act on it. She describes the test as "the most important appointment I almost didn't book."
Ovarian reserve declines with age in all women — but the rate varies enormously. Some 38-year-olds have the reserve of a 30-year-old; some 30-year-olds have the reserve of a 38-year-old. AMH tells you where you actually are — not where the average woman your age is.
An AMH result at 33 can change a life plan in a way that prevents regret at 38. It does not predict with certainty — but it gives the information needed to make informed decisions about timing.
If you're in your early 30s and planning to delay having children, an AMH test tells you what your ovaries are actually doing — not what the average woman your age is doing. Affordable, and fast, for information that changes timelines.
Book via WhatsApp — fast results on most tests, transparent pricing.